Literature DB >> 1087592

Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.

G Bjune, R S Barnetson.   

Abstract

The phytohaemagglutinin-induced responses of lymphocytes were found to be inhibited by plasma from patients with leprosy when compared with their responses in pooled serum from healthy donors. When patients developed reversal reactions, the initial inhibitory effect of their plasma was replaced by an augmentary effect on the responses to phytohaemagglutinin. The period of augmentation coincided with that of the reversal reaction in patients with borderline tuberculoid leprosy, but was delayed in patients with borderline lepromatous leprosy. The plasma from each leprosy patient was also observed to have the same effect on lymphocytes from unrelated individuals, showing that the inhibition and augmentation were due to factors in the plasma and not to a change in lymphocyte receptors. It is possible that the normal stable state of leprosy results from the presence of factors in plasma which act as a control mechanism, and that delayed hypersensitivity reactions may be caused by a breakdown of this control.

Entities:  

Mesh:

Year:  1976        PMID: 1087592      PMCID: PMC1540990     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.

Authors:  T Godal; B Myrvang; D R Samuel; W F Ross; M Lofgren
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1973

2.  Serum inhibitors of lymphocyte responses.

Authors:  R A Gatti
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

3.  Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.

Authors:  N Suciu-Foca; J Buda; J McManus; T Thiem; K Reemtsma
Journal:  Cancer Res       Date:  1973-10       Impact factor: 12.701

4.  Reactions in leprosy.

Authors:  D S Ridley
Journal:  Lepr Rev       Date:  1969-04       Impact factor: 0.537

5.  Phytohaemagglutinin-induced lymphocyte transformation in leprosy.

Authors:  D S Nelson; M Nelson; J M Thurston; M F Waters; J M Pearson
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

6.  In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.

Authors:  O Closs
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

8.  Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections.

Authors:  M G Fitzgerald; C S Hosking
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

9.  Antigenic heterogeneity in patients with reactions in borderline leprosy.

Authors:  R S Barnetson; G Bjune; J M Pearson; G Kronvall
Journal:  Br Med J       Date:  1975-11-22
  9 in total
  8 in total

1.  In vitro modulation of lymphocyte responses to phytohaemagglutinin by plasma in mother and baby at the time of birth. Increased lymphocyte responses in babies of mothers with lepromatous leprosy.

Authors:  G Bjune; E Duncan; R S Barnetson; R Melsom
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

2.  In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin.

Authors:  G Bjune
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

Review 3.  Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.

Authors:  G Bjune; O Closs; R S Barnetson
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Successful plasma exchange in type 1 leprosy reversal reaction.

Authors:  F Lucht; G Rifle; H Portier; J M Chalopin; J Bonhomme
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

5.  Studies on T cell subsets and functions in leprosy.

Authors:  M A Bach; L Chatenoud; D Wallach; F Phan Dinh Tuy; F Cottenot
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

6.  Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

Authors:  G M Bahr; G A Rook; E Moreno; P M Lydyard; F Z Modabber; J L Stanford
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

7.  Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  M A Kerr; Y M Hussein; R C Potts; J S Beck; M M Sheriff
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

8.  Effect of restricted dissolved oxygen on expression of Clostridium difficile toxin A subunit from E. coli.

Authors:  Ashish K Sharma; Jenie Phue; Emir Khatipov; Nimish Dalal; Eric D Anderson; Joseph Shiloach
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.